Literature DB >> 22959699

Advancing Alzheimer's disease diagnosis, treatment, and care: recommendations from the Ware Invitational Summit.

Mary D Naylor1, Jason H Karlawish, Steven E Arnold, Ara S Khachaturian, Zaven S Khachaturian, Virginia M-Y Lee, Matthew Baumgart, Sube Banerjee, Cornelia Beck, Kaj Blennow, Ron Brookmeyer, Kurt R Brunden, Kathleen C Buckwalter, Meryl Comer, Kenneth Covinsky, Lynn Friss Feinberg, Giovanni Frisoni, Colin Green, Renato Maia Guimaraes, Lisa P Gwyther, Franz F Hefti, Michael Hutton, Claudia Kawas, David M Kent, Lewis Kuller, Kenneth M Langa, Robert W Mahley, Katie Maslow, Colin L Masters, Diane E Meier, Peter J Neumann, Steven M Paul, Ronald C Petersen, Mark A Sager, Mary Sano, Dale Schenk, Holly Soares, Reisa A Sperling, Sidney M Stahl, Vivianna van Deerlin, Yaakov Stern, David Weir, David A Wolk, John Q Trojanowski.   

Abstract

To address the pending public health crisis due to Alzheimer's disease (AD) and related neurodegenerative disorders, the Marian S. Ware Alzheimer Program at the University of Pennsylvania held a meeting entitled "State of the Science Conference on the Advancement of Alzheimer's Diagnosis, Treatment and Care," on June 21-22, 2012. The meeting comprised four workgroups focusing on Biomarkers; Clinical Care and Health Services Research; Drug Development; and Health Economics, Policy, and Ethics. The workgroups shared, discussed, and compiled an integrated set of priorities, recommendations, and action plans, which are presented in this article.
Copyright © 2012 The Alzheimer's Association. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 22959699      PMCID: PMC3552530          DOI: 10.1016/j.jalz.2012.08.001

Source DB:  PubMed          Journal:  Alzheimers Dement        ISSN: 1552-5260            Impact factor:   21.566


  21 in total

1.  The diagnosis of dementia due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease.

Authors:  Guy M McKhann; David S Knopman; Howard Chertkow; Bradley T Hyman; Clifford R Jack; Claudia H Kawas; William E Klunk; Walter J Koroshetz; Jennifer J Manly; Richard Mayeux; Richard C Mohs; John C Morris; Martin N Rossor; Philip Scheltens; Maria C Carrillo; Bill Thies; Sandra Weintraub; Creighton H Phelps
Journal:  Alzheimers Dement       Date:  2011-04-21       Impact factor: 21.566

2.  Introduction to the recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease.

Authors:  Clifford R Jack; Marilyn S Albert; David S Knopman; Guy M McKhann; Reisa A Sperling; Maria C Carrillo; Bill Thies; Creighton H Phelps
Journal:  Alzheimers Dement       Date:  2011-04-21       Impact factor: 21.566

Review 3.  Overdiagnosis in cancer.

Authors:  H Gilbert Welch; William C Black
Journal:  J Natl Cancer Inst       Date:  2010-04-22       Impact factor: 13.506

Review 4.  Biomarkers and surrogate end points--the challenge of statistical validation.

Authors:  Marc Buyse; Daniel J Sargent; Axel Grothey; Alastair Matheson; Aimery de Gramont
Journal:  Nat Rev Clin Oncol       Date:  2010-04-06       Impact factor: 66.675

5.  Design of comprehensive Alzheimer's disease centers to address unmet national needs.

Authors:  John Q Trojanowski; Steven E Arnold; Jason H Karlawish; Kurt Brunden; Mark Cary; Christos Davatzikos; John Detre; Glen Gaulton; Murray Grossman; Howard Hurtig; Kathryn Jedrziewski; Leo McCluskey; Mary Naylor; Daniel Polsky; Gerard D Schellenberg; Andrew Siderowf; Leslie M Shaw; Vivianna Van Deerlin; Li-San Wang; Rachel Werner; Sharon X Xie; Virginia M-Y Lee
Journal:  Alzheimers Dement       Date:  2010-03       Impact factor: 21.566

6.  Developing a national strategy to prevent dementia: Leon Thal Symposium 2009.

Authors:  Zaven S Khachaturian; Deborah Barnes; Richard Einstein; Sterling Johnson; Virginia Lee; Allen Roses; Mark A Sager; William R Shankle; Peter J Snyder; Ronald C Petersen; Gerard Schellenberg; John Trojanowski; Paul Aisen; Marilyn S Albert; John C S Breitner; Neil Buckholtz; Maria Carrillo; Steven Ferris; Barry D Greenberg; Michael Grundman; Ara S Khachaturian; Lewis H Kuller; Oscar L Lopez; Paul Maruff; Richard C Mohs; Marcelle Morrison-Bogorad; Creighton Phelps; Eric Reiman; Marwan Sabbagh; Mary Sano; Lon S Schneider; Eric Siemers; Pierre Tariot; Jacques Touchon; Bruno Vellas; Lisa J Bain
Journal:  Alzheimers Dement       Date:  2010-03       Impact factor: 21.566

7.  Pedro Cuatrecasas.

Authors:  Pedro Cuatrecasas
Journal:  Nat Rev Drug Discov       Date:  2009-06       Impact factor: 84.694

8.  Creating a transatlantic research enterprise for preventing Alzheimer's disease.

Authors:  Zaven S Khachaturian; Jordi Camí; Sandrine Andrieu; Jesús Avila; Mercè Boada Rovira; Monique Breteler; Lutz Froelich; Serge Gauthier; Teresa Gómez-Isla; Ara S Khachaturian; Lewis H Kuller; Eric B Larson; Oscar L Lopez; José Manuel Martinez-Lage; Ronald C Petersen; Gerard D Schellenberg; Jordi Sunyer; Bruno Vellas; Lisa J Bain
Journal:  Alzheimers Dement       Date:  2009-07       Impact factor: 21.566

9.  Developing a global strategy to prevent Alzheimer's disease: Leon Thal Symposium 2010.

Authors:  Zaven S Khachaturian; Ronald C Petersen; Peter J Snyder; Ara S Khachaturian; Paul Aisen; Mony de Leon; Barry D Greenberg; Walter Kukull; Paul Maruff; Reisa A Sperling; Yaakov Stern; Jacques Touchon; Bruno Vellas; Sandrine Andrieu; Michael W Weiner; Maria C Carrillo; Lisa J Bain
Journal:  Alzheimers Dement       Date:  2011-03       Impact factor: 21.566

10.  The draft "National Plan" to address Alzheimer's disease - National Alzheimer's Project Act (NAPA).

Authors:  Zaven S Khachaturian; Ara S Khachaturian; William Thies
Journal:  Alzheimers Dement       Date:  2012-05       Impact factor: 21.566

View more
  20 in total

Review 1.  Progress update: fluid and imaging biomarkers in Alzheimer's disease.

Authors:  Courtney L Sutphen; Anne M Fagan; David M Holtzman
Journal:  Biol Psychiatry       Date:  2013-09-05       Impact factor: 13.382

2.  Amyloid-β immunization enhances neurogenesis and cognitive ability in neonatal mice.

Authors:  Hongguang Chen; Min Wang; Aihong Jiao; Guotai Tang; Wei Zhu; Peng Zou; Tuo Li; Guangqiang Cui; Peiyou Gong
Journal:  Int J Clin Exp Med       Date:  2015-04-15

Review 3.  Coffee, tea, and caffeine consumption and prevention of late-life cognitive decline and dementia: a systematic review.

Authors:  F Panza; V Solfrizzi; M R Barulli; C Bonfiglio; V Guerra; A Osella; D Seripa; C Sabbà; A Pilotto; G Logroscino
Journal:  J Nutr Health Aging       Date:  2015-03       Impact factor: 4.075

4.  The value of the GP's clinical judgement in predicting dementia: a multicentre prospective cohort study among patients in general practice.

Authors:  Michael Pentzek; Michael Wagner; Heinz-Harald Abholz; Horst Bickel; Hanna Kaduszkiewicz; Birgitt Wiese; Siegfried Weyerer; Hans-Helmut König; Martin Scherer; Steffi G Riedel-Heller; Wolfgang Maier; Alexander Koppara
Journal:  Br J Gen Pract       Date:  2019-10-31       Impact factor: 5.386

Review 5.  The nature, significance, and glucagon-like peptide-1 analog treatment of brain insulin resistance in Alzheimer's disease.

Authors:  Konrad Talbot; Hoau-Yan Wang
Journal:  Alzheimers Dement       Date:  2014-02       Impact factor: 21.566

6.  Advancing Research on Care Needs and Supportive Approaches for Persons With Dementia: Recommendations and Rationale.

Authors:  Ann Kolanowski; Richard H Fortinsky; Margaret Calkins; Davangere P Devanand; Elizabeth Gould; Tamar Heller; Nancy A Hodgson; Helen C Kales; Jeffrey Kaye; Constantine Lyketsos; Barbara Resnick; Melanie Schicker; Sheryl Zimmerman
Journal:  J Am Med Dir Assoc       Date:  2018-08-23       Impact factor: 4.669

7.  Cerebrovascular pathology and Alzheimer's disease.

Authors:  Peter T Nelson
Journal:  Lancet Neurol       Date:  2016-06-14       Impact factor: 44.182

Review 8.  Brain insulin resistance in Alzheimer's disease and its potential treatment with GLP-1 analogs.

Authors:  Konrad Talbot
Journal:  Neurodegener Dis Manag       Date:  2014

9.  Evaluation of Nootropic Activity of Limonia acidissima Against Scopolamine-induced Amnesia in Rats.

Authors:  Kailas K Mali; Guruprasad V Sutar; Remeth J Dias; Omkar A Devade
Journal:  Turk J Pharm Sci       Date:  2021-02-25

Review 10.  Comprehensive Management of Daily Living Activities, behavioral and Psychological Symptoms, and Cognitive Function in Patients with Alzheimer's Disease: A Chinese Consensus on the Comprehensive Management of Alzheimer's Disease.

Authors:  Jianjun Jia; Jun Xu; Jun Liu; Yongjun Wang; Yanjiang Wang; Yunpeng Cao; Qihao Guo; Qiuming Qu; Cuibai Wei; Wenshi Wei; Junjian Zhang; Enyan Yu
Journal:  Neurosci Bull       Date:  2021-05-29       Impact factor: 5.203

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.